Risks of autoimmune and inflammatory post-acute COVID-19 conditions: a network cohort study in six European countries, the USA and Korea
Theresa Ms Burkard, Kim López-Güell, Martí Català, Edward Burn, Antonella Delmestri, Sara Khalid, Annika M Jödicke, Daniel Dedman, Jessie Oyinlola, Alicia Abellan, Laura Pérez-Crespo, Núria Mercadé-Besora, Talita Duarte-Salles, Daniel Prieto-Alhambra, Johnmary Arinze, Mees Mosseveld, Raivo Kolde, Jaime Meléndez, Raúl López-Blasco, Álvaro Martínez, Bernardo Valdivieso, Dominique Delseny, Gregoire Mercier, Chungsoo Kim, Ji-Woo Kim, Kristin Kostka, Juan Manuel Ramírez-Anguita, Miguel Angel Mayer, Nhung T H Trinh, Hedvig Nordeng, Rogersyp Paredes, Anneli Uusküla, Akihiko Nishimura, Cora Loste, Lourdes Mateu, Junqing Xie · 2026
Read Risks of autoimmune and inflammatory post-acute COVID-19 conditions: a network cohort study in six European countries, the USA and Korea by Theresa Ms Burkard, Kim López-Güell, Martí Català, Edward Burn, Antonella Delmestri, Sara Khalid, Annika M Jödicke, Daniel Dedman, Jessie Oyinlola, Alicia Abellan, Laura Pérez-Crespo, Núria Mercadé-Besora, Talita Duarte-Salles, Daniel Prieto-Alhambra, Johnmary Arinze, Mees Mosseveld, Raivo Kolde, Jaime Meléndez, Raúl López-Blasco, Álvaro Martínez, Bernardo Valdivieso, Dominique Delseny, Gregoire Mercier, Chungsoo Kim, Ji-Woo Kim, Kristin Kostka, Juan Manuel Ramírez-Anguita, Miguel Angel Mayer, Nhung T H Trinh, Hedvig Nordeng, Rogersyp Paredes, Anneli Uusküla, Akihiko Nishimura, Cora Loste, Lourdes Mateu, Junqing Xie (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13404851.txt.
Description
Theresa Ms Burkard leads a 2026 network study of autoimmune and inflammatory illness after COVID-19 across nine countries. Records come from primary care, hospitals, registries and claims in Europe, the United States and Korea. Follow-up starts on day 91 after infection or a negative test, placing the focus on the post-acute period.
Conditions tracked include POTS, chronic fatigue syndrome conditions, multi-inflammatory syndrome and diseases such as rheumatoid arthritis and lupus. Patients are followed for up to a year, until an outcome, death or a new infection ends their record. A separate reinfection group shows whether a second infection changes risk. The design uses shared definitions so results can be compared across databases.
Catalog record
| CREATOR | Theresa Ms Burkard, Kim López-Güell, Martí Català, Edward Burn, Antonella Delmestri, Sara Khalid, Annika M Jödicke, Daniel Dedman, Jessie Oyinlola, Alicia Abellan, Laura Pérez-Crespo, Núria Mercadé-Besora, Talita Duarte-Salles, Daniel Prieto-Alhambra, Johnmary Arinze, Mees Mosseveld, Raivo Kolde, Jaime Meléndez, Raúl López-Blasco, Álvaro Martínez, Bernardo Valdivieso, Dominique Delseny, Gregoire Mercier, Chungsoo Kim, Ji-Woo Kim, Kristin Kostka, Juan Manuel Ramírez-Anguita, Miguel Angel Mayer, Nhung T H Trinh, Hedvig Nordeng, Rogersyp Paredes, Anneli Uusküla, Akihiko Nishimura, Cora Loste, Lourdes Mateu, Junqing Xie |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36098 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |